✦ LIBER ✦

FDA perspective on peptide formulation and stability issues

✍ Scribed by Chien-Hua Niu; Yuan-Yuan Chiu

Book ID: 109389062
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 36 KB
Volume: 87
Category: Article
ISSN: 0022-3549
DOI: 10.1021/js9800782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA Perspective on Regulatory Issues in

FDA Perspective on Regulatory Issues in Vaccine Development

✍ BASCOM F. ANTHONY 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Isobaric protein and peptide quantificat

Isobaric protein and peptide quantification: perspectives and issues

✍ Treumann, Achim; Thiede, Bernd 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 308 KB

Stability issues of covalently and nonco

Stability issues of covalently and noncovalently bonded peptide subunits

✍ András Perczel; Péter Hudáky; Anna K. Füzéry; Imre G. Csizmadia 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract The present study focuses on important questions associated with modeling of peptide and protein stability. Computing at different levels of theory (RHF, B3LYP) for a representative ensemble of conformers of di‐ and tripeptides of alanine, we found that the Gibbs Free Energy values corr

The FDA perspective on the development o

The FDA perspective on the development of stereoisomers

✍ Wilson H. De Camp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

School Perspective on Issues and Practic

School Perspective on Issues and Practice

✍ Lawrence J. Kilian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

FDA Issues Statement on Diethylene Glyco

FDA Issues Statement on Diethylene Glycol and Melamine Food Contamination

✍ Les Lang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB